The implication of "slow reacting substance of Anaphylaxis" SRS-A in the pathogenesis of asthma was realised in 1950. In recent years SRS-A has been shown to be a mixture of varied composition: The Leukotrienes (LT) C4, D4 and E4. These substances derive their arachidonic acid through the 5-lipoxygenase. The LT B4, which is not conjugated to glutathione (as compared to LT C4, D4 and E4) possesses powerful chemotactic activity and an (indirect) contractile effect on smooth muscle. LTC4, D4, E4 in vitro and in vivo, both by inhalation or intravenously, are powerful bronchoconstrictors clearly superior to histamine. The effects of C4 and LTD4 predominantly affect the peripheral airways.
1950年人们认识到“过敏反应迟缓反应物质”(SRS - A)在哮喘发病机制中的作用。近年来,SRS - A已被证明是一种成分各异的混合物:白三烯(LT)C4、D4和E4。这些物质通过5 - 脂氧合酶生成花生四烯酸。与LT C4、D4和E4相比,未与谷胱甘肽结合的LT B4具有强大的趋化活性和平滑肌(间接)收缩作用。LTC4、D4、E4无论是在体外还是体内,通过吸入或静脉注射,都是强大的支气管收缩剂,明显优于组胺。C4和LTD4的作用主要影响外周气道。